Sodium zirconium cyclosilicate

环硅酸锆钠

Report date: 2024/05/20 14:14:13
NME

Base Information

Drug NameSodium zirconium cyclosilicate
Drug Alias NameZirconium Silicate硅酸锆Ziconite利倍卓Zircon +[8] 
ClassificationSmall molecules > Inorganic and minerals salt
Mechanisms of ActionPotassium binders
TargetsPotassium
Therapy Area/IndicationsHyperkalemiaAcidosisHeart Failure, Systolic +[9] 
Global Approved IndicationsHyperkalemia
Approved Indications in ChinaHyperkalemia
Original Approved Country/TerritoryEU
Original Approved Date2018/03/22
Country/TerritoryCzechiaBulgariaCanada +[35] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZs Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceuticals LpAstrazeneca Pharmaceutical Co LtdAstrazeneca Plc +[5] 
Inactive CompaniesZs Texas LtdThe Brigham and Women's HospitalSharp Corp +[7] 
Active IndicationsHyperkalemiaHeart Failure, SystolicHeart Failure +[4] 
Inactive IndicationsAcidosisArrhythmias, CardiacHeart Diseases +[5] 

Other Information

ATC CodeV03AE10
Related LinksWikipediaDrugBankKEGG